Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PLECANATIDE, with a corresponding US DMF Number 34227.
Remarkably, this DMF maintains an Active status since its submission on November 27, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 14, 2021, and payment made on December 16, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II